Belvedere Trading’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,860
Closed -$126K 329
2024
Q2
$126K Buy
2,860
+659
+30% +$29K ﹤0.01% 111
2024
Q1
$111K Buy
+2,201
New +$111K ﹤0.01% 114
2023
Q4
Sell
-3,931
Closed -$224K 372
2023
Q3
$224K Buy
+3,931
New +$224K ﹤0.01% 46